LOSS OF RESPONSE AND DOSE ESCALATION OF INFLIXIMAB AND ADALIMUMAB IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Edo Savelkoul  ¹     Pepijn Thomas     Nathan Den Broeder     Tessa E.H. Römkens  ²     Frank Hoentjen  ^3    
1 Radboudumc, Nijmegen, Netherlands
² Jeroen Bosch Hospital, Den Bosch, Netherlands
³ University of Alberta, Edmonton, Canada

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)